Tool overview
RagaAI is listed under AI Governance Safety & Evaluation AI tools.
What is RagaAI?
RagaAI provides production-grade AI agent suites for healthcare, life sciences, and aerospace, alongside Catalyst, Neo, and Prism testing capabilities for generative, agentic, computer-vision, NLP, and structured-data systems. It supports evaluation, tracing, root-cause analysis, guardrails, and enterprise deployment.
Best for
Regulated enterprises evaluating and deploying production AI agents
Who is it for?
Decision note
Confirm the current product scope, supported modalities, evaluation metrics, guardrails, deployment, data residency, regulated-domain validation, security, implementation, support, and pricing.
Key features
Healthcare and life-science agent suites
Catalyst LLM testing and guardrails
Neo agentic-system evaluation
Prism computer-vision testing
Tracing and root-cause analysis
Enterprise deployment and monitoring
Use cases
Testing generative AI applications
Evaluating agent reliability
Monitoring healthcare agent workflows
Finding computer-vision failure modes
Pros
- Supports multiple AI modalities
- Public documentation and sandbox exist
- Verified support emails are published
Cons
- Commercial pricing requires consultation
- Product portfolio is technically complex
- Regulated outputs need domain validation
Limitations
RagaAI evaluations and agents can miss failures, produce false confidence, or behave differently in production. Organizations must validate datasets, metrics, traces, guardrails, bias, clinical or engineering context, and every consequential action.
Pricing details
Billing options
Custom enterprise agreement
Pricing note
RagaAI uses enterprise consultation and does not publish a stable starting amount. A public Prism sandbox demonstrates capabilities but does not establish an ongoing free commercial plan or formal trial.
Supported languages
- English
Integrations
LLM applications
Agentic systems
Computer-vision pipelines
NLP systems
Structured-data applications
Please log in to join the discussion.